Exelon (EXC)

Total Costs & Expenses

$20.06B

TTM · Period ending: · USD

EXC logo

EXC Total Costs & Expenses

Latest reported$20.06B
EXC TTM Total Costs & Expenses ($3.09B → $20.06B)
High-resolution chart · PNG

EXC total costs & expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Exelon Total Costs & Expenses — Trailing twelve months (TTM) (USD)
Period endingTotal Costs & Expenses (USD)
20,061,000,000
19,573,000,000
19,114,000,000
19,255,000,000
19,009,000,000
18,957,000,000
18,708,000,000
18,610,000,000
18,509,000,000
18,175,000,000
17,703,000,000
17,385,000,000
16,362,000,000
15,793,000,000
15,763,000,000
20,819,000,000
21,092,000,000
20,987,000,000
20,368,000,000
19,200,000,000
23,177,000,000
26,494,000,000
30,213,000,000
29,748,000,000
29,240,000,000
29,331,000,000
30,063,000,000
30,789,000,000
31,470,000,000
31,756,000,000
32,089,000,000
31,105,000,000
30,117,000,000
30,348,000,000
29,195,000,000
29,234,000,000
29,700,000,000
28,598,000,000
28,249,000,000
27,081,000,000
25,547,000,000
24,664,000,000
25,038,000,000
25,596,000,000
24,569,000,000
24,371,000,000
23,976,000,000
22,699,000,000
22,773,000,000
22,727,000,000
21,232,000,000
21,538,000,000
22,266,000,000
22,382,000,000
21,139,000,000
18,487,000,000
16,584,000,000
14,794,000,000
14,217,000,000
14,843,000,000
14,695,000,000
14,613,000,000
13,918,000,000
13,404,000,000
12,415,000,000
12,160,000,000
12,568,000,000
12,688,000,000
13,567,000,000
13,634,000,000
13,561,000,000
14,452,000,000
14,318,000,000
14,396,000,000
14,640,000,000
13,136,000,000
13,418,000,000
12,643,000,000
12,048,000,000
13,755,000,000
12,953,000,000
13,045,000,000
12,632,000,000
11,115,000,000
10,504,000,000
10,502,000,000
10,736,000,000
10,916,000,000
12,801,000,000
13,137,000,000
13,590,000,000
13,501,000,000
12,436,000,000
12,221,000,000
11,656,000,000
11,440,000,000
11,343,000,000
11,461,000,000
11,643,000,000
11,742,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.